Supplemental educational content
Evidence Shows Higher Risk of C. difficile Infection with PPIs
AJG Author Podcasts
Findings from a new meta-analysis portray a cautionary tale on the use of PPI therapy in patients at significant risk of C. difficile infection. In conversation with AJG Co-Editor, Dr. William D. Chey, MD, Dr. Yoon K. Loke discusses his research findings that suggest concurrent use of antibiotics with PPIs increases the risk of CDI; and a lower risk of CDI with use of H2RAs. (17:00)
The Role of Fecal Microbiota Transplant in Treating C. difficile
AJG Author Podcasts
William D. Chey, MD, FACG, talks with Lawrence J. Brandt, MD, MACG, on the efficacy of this potentially lifesaving procedure and how the FDA’s recent classification of stool as a “drug” could impact physicians who want to use FMT as a treatment option for their patients. A leading pioneer in the use of fecal microbiota transplantation (FMT) in treating C. difficile infection, Dr. Brandt gave the 2012 AJG Lecture that was also published in the February issue. (33:10)
The Role of Fecal Microbiota Transplant (FMT) in Treating C. difficile
Youtube (AJG Channel)
ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile
Youtube (AJG Channel)
Evidence Shows Higher Risk of C. diff Infection with PPIs – A Podcast with Yoon K. Loke, MD, MBBE
Youtube (AJG Channel)
Fecal Transplantation for Clostridium difficile Infection
Youtube (AJG Channel)
Learning Objective: Explain the current state of fecal transplantation for C. difficile infection.
New Paradigms in the Management of C. difficile
Youtube (AJG Channel)
Learning Objective: Report recent changes in the approach to treating C. difficile colitis.
© 2026 Wolters Kluwer. All right reserved.